🔥 Gündem Shingles Vaccine and Heart Health: What You Need to Know

The shingles vaccine, primarily known for preventing the painful viral disease herpes zoster (shingles), has increasingly been linked to significant cardiovascular benefits, including a reduced risk of heart attack and stroke ⁵¹⁰. This connection has been highlighted by recent studies and meta-analyses, suggesting that the vaccine offers protection beyond its original purpose ²¹⁰.

Understanding Shingles and Its Cardiovascular Impact

Shingles is caused by the varicella-zoster virus (VZV), the same virus that causes chickenpox ⁴⁶. After a person recovers from chickenpox, the VZV remains dormant in nerve cells and can reactivate later in life, leading to shingles ⁴. The disease is characterized by a painful skin rash with blisters, typically on one side of the face or torso ¹⁶.

While the exact biological mechanisms are still being investigated, scientists believe the link between shingles and cardiovascular events stems from the inflammatory response triggered by the VZV ⁴. When the virus reactivates, it can cause inflammation in blood vessels, potentially leading to damage that increases the risk of cardiovascular problems like heart attack and stroke ⁴. By preventing shingles, the vaccine may also prevent this inflammatory cascade, thereby protecting the cardiovascular system.

Evidence of Cardiovascular Benefits from Shingles Vaccination

Recent research has provided compelling evidence for the cardiovascular protective effects of the shingles vaccine:

• Reduced Risk of Cardiovascular Events: A new global systematic literature review and meta-analysis, presented at the 2025 European Society of Cardiology Congress, indicated that shingles vaccination is associated with a statistically significant lower risk of heart attack and stroke ⁵.
• Specific Risk Reductions: A study involving over a million people, published in the European Heart Journal, found that individuals who received the shingles vaccine had a 23% lower risk of cardiovascular events. This included a reduced risk of stroke, heart failure, and coronary heart disease ⁸.
• Duration of Protection: The protective benefit against cardiovascular events has been observed to last for up to eight years after vaccination ²⁸.
• Benefits for Individuals with Existing Heart Disease: Research also suggests that the shingles vaccine is linked to a significantly lower risk of major cardiovascular events in people who already have existing heart disease. Vaccinated individuals in this group showed reduced risks across multiple outcomes, including heart attack, stroke, and heart failure ⁹.

The Mechanism Behind the Link

While the precise mechanisms are still being unraveled, current theories suggest that the shingles vaccine's cardiovascular benefits are tied to its ability to prevent the downstream harms of the varicella-zoster virus ⁴. When VZV reactivates, it can trigger systemic inflammation and damage to blood vessels, which are known risk factors for cardiovascular diseases. By preventing shingles, the vaccine effectively mitigates this inflammatory response, thereby reducing the risk of associated cardiovascular complications.

It is important to note that while these findings are promising, some studies have primarily focused on specific populations, such as Asian cohorts. Authors of these studies recommend further testing in other populations to confirm these effects universally ⁷.

Broader Health Implications

The growing body of evidence suggests that the shingles vaccine offers health benefits that extend beyond simply preventing shingles ⁷¹⁰. This dual protection against a painful viral infection and serious cardiovascular events underscores the importance of vaccination as a public health measure. As research continues, a deeper understanding of these mechanisms could lead to new insights into both viral infections and cardiovascular disease prevention.